Literature DB >> 32977230

Lack of APOE Christchurch variant in five age of onset outliers with PSEN1, PSEN2 Alzheimer's disease and MAPT frontotemporal dementia.

Chang-En Yu1, Sunny Chen2, Suman Jayadev3, Thomas Bird4.   

Abstract

INTRODUCTION: Age of onset modifiers are of considerable importance in Alzheimer's and related dementias. Arboleda-Valesquez et al., reporting on a single PSEN1 subject, suggested that homozygosity for the Christchurch variant of APOE could represent such a modifier.
METHODS: We studied APOE Christchurch and Kloth-VS genotypes of five dementia age of onset outliers who carried their families' pathogenic variant, but were asymptomatic at ages beyond the families' average age of onset.
RESULTS: Four age of onset outliers with PSEN1/2 and MAPT mutations did not carry the Christchurch variant and a fifth individual was also determined to not be homozygous for this variant. Among them, only one subject (APOE ε3/ε3) carries the Klotho-VS heterozygous genotype. DISCUSSION: From a small but informative sample of five age of onset outliers we show that neither the APOE Christchurch nor the Klotho-VS variant is a common age of onset modifier for three genetic forms of dementia. Larger studies of this association and further research is required to identify additional genetic modifiers.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  APOE; Alzheimer's disease; Christchurch mutation; Dementia; Modifiers

Mesh:

Substances:

Year:  2020        PMID: 32977230      PMCID: PMC7606829          DOI: 10.1016/j.jns.2020.117143

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.

Authors:  Suman Jayadev; James B Leverenz; Ellen Steinbart; Justin Stahl; William Klunk; Cheng-En Yu; Thomas D Bird
Journal:  Brain       Date:  2010-04       Impact factor: 13.501

Review 2.  Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes.

Authors:  R W Mahley; Y Huang; S C Rall
Journal:  J Lipid Res       Date:  1999-11       Impact factor: 5.922

3.  Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.

Authors:  Michael E Belloy; Valerio Napolioni; Summer S Han; Yann Le Guen; Michael D Greicius
Journal:  JAMA Neurol       Date:  2020-07-01       Impact factor: 18.302

4.  Unusually long duration and delayed penetrance in a family with FTD and mutation in MAPT (V337M).

Authors:  Kimiko Domoto-Reilly; Marie Y Davis; C Dirk Keene; Thomas D Bird
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-03-16       Impact factor: 3.568

5.  Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease.

Authors:  Kiri L Brickell; James B Leverenz; Ellen J Steinbart; Malia Rumbaugh; Gerard D Schellenberg; David Nochlin; Thomas H Lampe; Ida E Holm; Vivianna Van Deerlin; Wuxing Yuan; Thomas D Bird
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07-05       Impact factor: 10.154

6.  Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions.

Authors:  A Lalazar; K H Weisgraber; S C Rall; H Giladi; T L Innerarity; A Z Levanon; J K Boyles; B Amit; M Gorecki; R W Mahley
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

7.  Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.

Authors:  Caitlin S Latimer; Bridget T Burke; Nicole F Liachko; Heather N Currey; Mitchell D Kilgore; Laura E Gibbons; Jonathan Henriksen; Martin Darvas; Kimiko Domoto-Reilly; Suman Jayadev; Tom J Grabowski; Paul K Crane; Eric B Larson; Brian C Kraemer; Thomas D Bird; C Dirk Keene
Journal:  Acta Neuropathol Commun       Date:  2019-06-07       Impact factor: 7.578

8.  ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology.

Authors:  Carolin Koriath; Tammaryn Lashley; William Taylor; Ronald Druyeh; Athanasios Dimitriadis; Nicola Denning; Julie Williams; Jason D Warren; Nick C Fox; Jonathan M Schott; James B Rowe; John Collinge; Jonathan D Rohrer; Simon Mead
Journal:  Alzheimers Dement (Amst)       Date:  2019-03-19

9.  Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.

Authors:  Joseph F Arboleda-Velasquez; Francisco Lopera; Michael O'Hare; Santiago Delgado-Tirado; Claudia Marino; Natalia Chmielewska; Kahira L Saez-Torres; Dhanesh Amarnani; Aaron P Schultz; Reisa A Sperling; David Leyton-Cifuentes; Kewei Chen; Ana Baena; David Aguillon; Silvia Rios-Romenets; Margarita Giraldo; Edmarie Guzmán-Vélez; Daniel J Norton; Enmanuelle Pardilla-Delgado; Arabiye Artola; Justin S Sanchez; Juliana Acosta-Uribe; Matthew Lalli; Kenneth S Kosik; Matthew J Huentelman; Henrik Zetterberg; Kaj Blennow; Rebecca A Reiman; Ji Luo; Yinghua Chen; Pradeep Thiyyagura; Yi Su; Gyungah R Jun; Marcus Naymik; Xiaowu Gai; Moiz Bootwalla; Jianling Ji; Lishuang Shen; John B Miller; Leo A Kim; Pierre N Tariot; Keith A Johnson; Eric M Reiman; Yakeel T Quiroz
Journal:  Nat Med       Date:  2019-11-04       Impact factor: 53.440

10.  The mutational constraint spectrum quantified from variation in 141,456 humans.

Authors:  Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 69.504

  10 in total
  1 in total

Review 1.  The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.

Authors:  Giovanni B Frisoni; Daniele Altomare; Dietmar Rudolf Thal; Federica Ribaldi; Rik van der Kant; Rik Ossenkoppele; Kaj Blennow; Jeffrey Cummings; Cornelia van Duijn; Peter M Nilsson; Pierre-Yves Dietrich; Philip Scheltens; Bruno Dubois
Journal:  Nat Rev Neurosci       Date:  2021-11-23       Impact factor: 34.870

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.